	US 12,070,566 B2
	Oral delivery of active drug substances
Nikolaj Skak, Rungsted Kyst (DK); Karsten Lindhardt, Haslev (DK); Torben Elhauge, Kobenhavn K (DK); and Martin Rex Olsen, Farevejle (DK)
Assigned to Biograil ApS, Roskilde (DK)
Filed by Biograil ApS, Roskilde (DK)
Filed on Aug. 18, 2022, as Appl. No. 17/820,750.
Application 17/820,750 is a continuation of application No. 16/771,965, granted, now 11,452,851, previously published as PCT/EP2018/085502, filed on Dec. 18, 2018.
Claims priority of application No. PA 201770955 (DK), filed on Dec. 18, 2017.
Prior Publication US 2023/0073256 A1, Mar. 9, 2023
Int. Cl. A61M 31/00 (2006.01); A61K 9/00 (2006.01)

CPC A61M 31/002 (2013.01) [A61K 9/0053 (2013.01)]

20 Claims

1. A delivery device for a composition, the delivery device comprising a body and a delivery part, the body extending along a body axis from a first body end to a second body end and having a body surface, the delivery part comprising a first attachment part, the first attachment part having a first distal end, wherein the first attachment part comprises a first bend and extends along a first axis, wherein a first angle between the first axis and the body axis is less than 75 degrees.